3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Spinal Fractures
2
Neoplasms
2
Multiple Myeloma
2
Spinal Diseases
1
Solid Tumors
1
Interventions
Paclitaxel
4
tocilizumab
2
pembrolizumab
2
zansecimab
1
tivozanib
1
temsirolimus
1
spartalizumab
1
ridaforolimus
1
parsaclisib
1
olaparib
1
obinutuzumab
1
motesanib diphosphate
1
liposomal doxorubicin
1
itacitinib
1
epacadostat
1
durvalumab
1
birinapant
1
atezolizumab
1
Vertebroplasty
1
Temozolomide
1
TAK-981
1
Ramucirumab
1
Panobinostat
1
Oxaliplatin
1
Leucovorin
1
Kyphoplasty
1
IT-101
1
INCB039110
1
Gemcitabine
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Solid Tumors
×
Kyphoplasty
×
Clear all
NCT02700308
2022-07-28
KYPHO-01
Centre Leon Berard
Phase 2
Terminated
31 enrolled